The TIGRIS trial results have been published in The Lancet Respiratory Medicine. In patients with endotoxic septic shock, Polymyxin B Hemoadsorption is associated with a high probability of lower mortality at 28 and 90 days. The Tigris trial shows a clinically meaningful signal of reduced mortality with polymyxin B in patients with ESS, alongside an acceptable safety profile.
ESTOR has obtained ISO 13485 certification, the international reference standard for quality management systems in the medical device sector. This achievement is a concrete recognition of the company’s ongoing commitment to safety, regulatory compliance, and the high performance of its products, further confirming its position as a reliable and innovative partner in the medical field.
Positive topline results from the Tigris trial have just been announced. This phase 3 follow-on sponsored study evaluates the use of Polymyxin B Hemoadsorption (“PMX” – Toray Medical Inc, Tokyo) in a randomized clinical trial of adults treated for Endotoxic Septic Shock (ESS) selected using the Endotoxin Activity Assay (EAA – Spectral Medical Inc., Toronto).
The 43rd VICENZA COURSE on AKI-CRRT-EBPT and Critical Care Nephrology (June 24-26) is approaching. On June 25 at 2 pm, we will support the Meet The Expert session “Sepsis-Associated AKI and EBPTs approach: ‘endotype’, ‘dose’ or ‘membrane’? That’s the question” where key experts will discuss the most recent findings and clinical strategies for endotoxic shock management.
The 36th SMART Meeting (Smart Meeting Anesthesia Resuscitation Intensive Care) is approaching and will take place from May 7 to 9, 2025, in Milan—Allianz MiCO.
We are partnering with SMART, and on May 7, we will support the session “Clinical Challenges in the ICU and Advanced ExtraCorporeal Organ Support.”
The 26th National Congress of the Italian Society for Neonatal and Pediatric Anesthesia and Resuscitation (SARNePI) will take place in Rome on November 07-09, 2024.
We are a partner of SARNePI and on November 8, we will support the lecture “Sistemi di depurazione endotossinica nella sepsi pediatrica. Esperienza in OPBG”
The 28th International Symposium on Infections in the Critically Ill (ISICIP) will take place in Barcelona on November 07-08, 2024.
We will be present at ISICIP with our partner Direx. On November 7, we will support the symposium “Endotoxin (Septic) Shock: Role of Advanced Blood Purification Therapies.”
The 65th National Congress of the Italian Society of Nephrology (SIN) will be held in Riccione from October 16 to 19, 2024.
Estor is a partner of SIN, and in addition to our presence with an exhibition area, on October 17 and 18, we will host the breakfast sessions “Immunoprotezione e Immunomodulazione nel paziente HD: back to dialysis membrane” and “Septic AKI (SA-AKI): definizione e approccio terapeutico.”
The 78th National Congress of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) will take place in Naples from October 10 to 12, 2024. Estor is a partner of SIAARTI, and in addition to our presence with an exhibition area, we will support the symposium “Cutting Edge EBPs for Organ Support in Critical Care: Hemoadsorption and ECCO2R” on October 10.